FDA free to pursue semaglutide compounders after latest court ruling
Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final resolution.
Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final resolution.
What's Your Reaction?
